Authors
Latest:
Exploring the Potential Therapeutic Avenue of BTK Inhibitors for Progressive MS: Amit Bar-Or, MD, FRCPC, FAAN, FANAThe Melissa and Paul Anderson President’s Distinguished Professor of Neurology, Perelman School of Medicine, University of Pennsylvania, discussed the promising avenue of BTK inhibitors for addressing progressive multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Brian J. Murray, MD: Establishing Normal Values in PolysomnographyThe head of neurology at the Sunnybrook Health Sciences Centre of the University of Toronto spoke about the limited available normative sleep data, and shared insight into the findings of the meta-analysis he and colleagues conducted of more than 150 studies.
Latest:
Progress for Patients With Pediatric MS, Fingolimod's Risk-Benefit Profile: Brenda Banwell, MDThe chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke about her presentation at ECTRIMS 2022 on the treatment of pediatric MS. [WATCH TIME: 5 minutes]
Latest:
Thorsten Mikoteit, MD: Sleep Research, an Excellent Source for BiomarkersThe Psychiatrist at Psychiatric Services Solothurn and University of Basel discussed how heart rate variability correlates with sleep stages, which may indicate nocturnal brain activity.
Latest:
Lifestyle Change for Migraine Management: Practical Tips for the Neurologist and PCP, Part 2Trigger avoidance-only strategies don’t actually help migraine patients improve. These are the proactive behaviors that do.
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
The Challenges of Stroke Care in Rural AmericaStroke care, including acute treatment and prevention, faces unique challenges in rural areas where disease awareness is lacking and access to high-level care in scarce.
Latest:
The Potential of NLRX1 in Immune Regulation and Neuroprotection for Inflammatory Neurodegenerative Disorders: Marjan Gharagozloo, PhDThe assistant professor of neurology at Johns Hopkins Medicine talked about her preclinical research in immunology to explore the intricate mechanisms controlling chronic inflammation in the central nervous system. [WATCH TIME: 5 minutes]
Latest:
Jonathan Voglein, MD: Epilepsy in Alzheimer DiseaseThis data demonstrates that patients with Alzheimer disease are at an increased risk for seizures, in particular in more advanced disease stages, which emphasizes a need for seizure history assessment to inform individual therapeutic decisions and the necessity of systematic treatment studies.
Latest:
Ronald Crystal, MD: The Possibilities of Gene Therapy in Neurodegenerative DiseaseThe chairman of the Department of Genetic Medicine at Weill Cornell Medicine detailed the ongoing research in developing gene therapy for patients with Alzheimer disease.
Latest:
Anna Heidbreder, MD: Anti-IgLON5 Disease, REM Sleep Behavior DisorderHeidbreder further described the current understanding of the condition and what she and her colleagues have found out.
Latest:
Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer DiseaseThe associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.
Latest:
Neurologic Complications of COVID-19 ReportedThe first presumptive case of acute necrotizing encephalopathy in a patient with confirmed COVID-19 has been published in the journal Radiology.
Latest:
Sanjeev V. Thomas, MD, DM: Managing Epilepsy During PregnancyThe chief of neurology at Sree Chitra Tirunal Institute for Medical Sciences and Technology spoke about how to reassure patients with epilepsy who are planning for pregnancy and how to make treatment decisions with pregnant patients.
Latest:
Bruce Trapp, PhD: Insights Gleaned from Myelocortical Multiple SclerosisThe chairman of the Department of Neuroscience at the Lerner Research Institute spoke about what the implications of the new subtype of MS could be in the understanding of the disease.
Latest:
Rick Wassing, MSc, PhD-C: Restless REM Sleep Contributes to Hyperarousal In InsomniaThose suffering from significant emotional distress and sleep disturbances may benefit from targeted interventions to restore consolidated REM sleep or prevent the occurrence of fragmented REM sleep.
Latest:
World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and DementiaIn recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.
Latest:
ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MDThe director of the Mellen Center for MS at Cleveland Clinic talked about the ENSEMBLE study results that were presented at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
Lisa Eunyoung Lee, MS, BSc: Myelin Water Imaging in the Spinal CordThe research assistant at the University of British Columbia-Vancouver detailed the success of myelin water imaging in the spinal cords of both healthy controls and patients with multiple sclerosis.
Latest:
Advice for Managing Dravet Syndrome and LGSMary Anne Meskis; Tracy Dixon-Salazar, PhD; Kelly Knupp, MD; and Joseph E. Sullivan, MD, provide advice for physicians treating patients with Dravet syndrome or LGS.
Latest:
COMT Inhibitors Assist in Control of Parkinson Disease Motor SymptomsMore recently, investigators have discovered that catechol-O-methyltransferase inhibitors can prolong the effects of levodopa, thereby limiting the off-time phenomenon.
Latest:
Lynn Liu, MD: When Should We Measure Antiepileptic Blood Levels?The associate professor of neurology at the University of Rochester shared some of her advice for treating patients with epilepsy and focusing on the patient.
Latest:
California Startup Exploring Novel ALS Discovery PlatformA grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.
Latest:
David Kemlink, MD, PhD: Actigraphic Recordings in Rapid Eye Movement Sleep Behavior DisorderActigraphic recording from upper extremities show consistently more prominent sleep fragmentation in rapid eye movement sleep behavior disorder patients compared to other sleep diagnoses.
Latest:
Page B. Pennell, MD: Improving Epilepsy Care in 2020 and BeyondThe president of the American Epilepsy Society and director of epilepsy research at Brigham and Women’s Hospital outlined the state of epilepsy care and what we can expect in 2020.
Latest:
Paul Durham, PhD: A Combination Approach With nVNS in MigraineThe distinguished professor and director of cell biology at Missouri State University discussed the use of nVNS in migraine treatment and whether or not it can replace the use of or be used in conjunction with triptans—a medication on which many patients fail or report poor response on.
Latest:
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s DiseaseDrs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
The Treatment of Status Migrainosus in Emergency Care Settings: Matthew Robbins, MDThe neurologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital offered his insight into the state of treatment for status migrainosus and whether or not the new migraine medications can help improve care. [WATCH TIME: 2 minutes]
